
Conference Coverage
Latest Content

Career Insights From a Dermatologist Specializing in Skin of Color

FDA Expands Upadacitinib Label for Treating Inflammatory Bowel Disease

Medicare Beneficiaries With HIV More Likely to Have OUD

The Biosimilar Shift: Trending Infliximab Biosimilar Utilization and Associated Cost Savings for Commercial Insurance

Prescription Access Crisis: 40% of GLP-1 RA Rx Are Unfilled

Shorts










Podcasts
Center on Health Equity & Access
Continuing Medical Education
All News

WHO's latest report shows alarming trends in antimicrobial resistance, highlighting urgent global challenges and the need to improve surveillance and treatment.

Lindsey Valenzuela, PharmD, explains how pharmacists can prevent drug interactions and improve coordination for women with arrhythmia and chronic disease.

A Mendelian randomization study suggests Actinomyces plays a role in idiopathic pulmonary fibrosis, mediated by circulating inflammatory proteins.

An innovative artificial intelligence (AI) tool enhanced alopecia areata assessment and improved treatment adherence.

A 12-year study in China finds that individuals who dine out often face a higher risk of colon and rectal cancers, with obesity playing a mediating role.

Experts at the Skin of Color Update highlighted the potential benefits of GLP-1 RAs in managing obesity, as well as psoriasis and hidradenitis suppurativa symptom management.

Allergen immunotherapy was associated with reduced medication use and improved asthma control for up to 9 years.

Arthritis is not one disease, and it has an impact that extends far beyond the well-known osteoarthritis or rheumatoid arthritis.

Online racial discrimination, bias, and trauma are linked to anxiety and depression in Black adolescents.

AstraZeneca has struck a deal with the Trump administration to sell lower-priced drugs via TrumpRx, following a similar agreement with Pfizer.